NCT05454267 Early Detection of Vaping-related Vascular Diseases
| NCT ID | NCT05454267 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Miami |
| Condition | Vaping |
| Study Type | OBSERVATIONAL |
| Enrollment | 90 participants |
| Start Date | 2022-09-12 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 90 participants in total. It began in 2022-09-12 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine how vaping affects blood vessels, in particular if early damage occurs in the lung vessels.
Eligibility Criteria
Inclusion Criteria: Vapers Group: 1. Current electronic cigarette (EC) Puff Bar users defined as using EC either daily or occasionally in the past 30 days for at least 6 months, and with 5% nicotine concentration pods. 2. Adults aged 18-40 years Healthy Group: 1. Healthy never smokers, never vapers 2. Adults aged 18-40 years Exclusion Criteria: 1. Current or past smoking of tobacco cigarette (TC) or other tobacco/nicotine products (e.g., smokeless tobacco, Hookah) or marijuana will be excluded from the study. 2. Subjects with self-reported history of chronic health problems including asthma, chronic obstructive pulmonary disease (COPD), morbid obesity (BMI\>40 kg/m2), hypertension or diabetes 3. Pregnant or breastfeeding women
Contact & Investigator
Adam Wanner, MD
PRINCIPAL INVESTIGATOR
University of Miami
Frequently Asked Questions
Who can join the NCT05454267 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Vaping. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05454267 currently recruiting?
Yes, NCT05454267 is actively recruiting participants. Contact the research team at awanner@med.miami.edu for enrollment information.
Where is the NCT05454267 trial being conducted?
This trial is being conducted at Miami, United States.
Who is sponsoring the NCT05454267 clinical trial?
NCT05454267 is sponsored by University of Miami. The principal investigator is Adam Wanner, MD at University of Miami. The trial plans to enroll 90 participants.